PHVS

Pharvaris N.V.

Price Chart

No historical data available

Latest Quote

$35.32

-1.68 (-4.54%)

Current Price

Previous Close	$37.00
Open	$37.00
Day High	$37.41
Day Low	$35.36
Volume	478,507

Fetched: 2026-08-29T23:27:32

Stock Information

Note: Financial values converted from EUR to USD

Shares Outstanding	70.20M
Total Debt	$781K
Cash Equivalents	$368.81M
Net Income	$-198.05M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$2.48B
EPS (TTM)	$-2.90
Exchange	NMS

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Pharvaris N.V.

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.

📰 Latest News

No news articles available at the moment. Check back later for updates on PHVS.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Expenses
Total Expenses	$198,021,147	$169,878,930	$113,005,623	$101,113,118
Other Income Expense	$-11,952,833	$9,175,739	$-3,634,168	$12,943,554
Net Non Operating Interest Income Expense	$7,418,593	$6,322,936	$237,895	$-45,772
Total Other Finance Cost	$-7,418,593	$-6,322,936	$-237,895	$45,772
Operating Expense	$198,021,147	$169,878,930	$113,005,623	$101,113,118
General And Administrative Expense	$52,873,833	$54,949,439	$36,542,200	$34,210,628
Interest Expense	-	-	-	$18,779
Interest Expense Non Operating	-	-	-	$18,779
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-204,873,368	$-156,508,314	$-117,624,848	$-89,007,181
Net Interest Income	$7,418,593	$6,322,936	$237,895	$-45,772
Normalized Income	$-196,004,366	$-163,316,712	$-114,928,296	$-98,611,299
Net Income From Continuing And Discontinued Operation	$-204,873,368	$-156,508,314	$-117,624,848	$-89,007,181
Net Income Common Stockholders	$-204,873,368	$-156,508,314	$-117,624,848	$-89,007,181
Net Income	$-204,873,368	$-156,508,314	$-117,624,848	$-89,007,181
Net Income Including Noncontrolling Interests	$-204,873,368	$-156,508,314	$-117,624,848	$-89,007,181
Net Income Continuous Operations	$-204,873,368	$-156,508,314	$-117,624,848	$-89,007,181
Pretax Income	$-202,555,387	$-154,380,254	$-116,401,895	$-88,215,335
Operating Income	$-198,021,147	$-169,878,930	$-113,005,623	$-101,113,118
Per Share
Diluted EPS	$-3.46	$-2.89	$-3.07	$-2.65
Basic EPS	$-3.46	$-2.89	$-3.07	$-2.65
Other
Tax Effect Of Unusual Items	$-3,083,831	$2,367,341	$-937,615	$3,339,437
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-185,580,496	$-178,740,348	$-109,071,139	$-113,878,336
Total Unusual Items	$-11,952,833	$9,175,739	$-3,634,168	$12,943,554
Total Unusual Items Excluding Goodwill	$-11,952,833	$9,175,739	$-3,634,168	$12,943,554
Reconciled Depreciation	$487,818	$314,321	$300,316	$178,336
EBITDA (Bullshit earnings)	$-197,533,328	$-169,564,608	$-112,705,307	$-100,934,782
EBIT	$-198,021,147	$-169,878,930	$-113,005,623	$-101,113,118
Diluted Average Shares	$68,982,332	$62,990,380	$44,766,389	$39,162,753
Basic Average Shares	$68,982,332	$62,990,380	$44,766,389	$39,162,753
Diluted NI Availto Com Stockholders	$-204,873,368	$-156,508,314	$-117,624,848	$-89,007,181
Tax Provision	$2,317,982	$2,128,060	$1,222,954	$791,846
Gain On Sale Of Security	$-11,952,833	$9,175,739	$-3,634,168	$12,943,554
Research And Development	$145,147,314	$114,929,490	$76,463,423	$66,902,490
Selling General And Administration	$52,873,833	$54,949,439	$36,542,200	$34,210,628
Other Gand A	$25,891,764	$32,930,190	$21,017,061	$18,486,519
Salaries And Wages	$26,982,069	$22,019,250	$15,525,139	$15,724,109
Insurance And Claims	-	-	$7,033,014	$7,513,653

Fetched: 2026-08-25

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$316,318,027	$312,221,020	$447,817,643	$174,042,716
Total Assets	$351,510,034	$339,756,030	$464,895,608	$195,584,173
Total Non Current Assets	$2,666,480	$2,279,838	$983,092	$1,033,398
Non Current Deferred Assets	$1,034,692	$553,110	$451,876	$302,942
Non Current Deferred Taxes Assets	$1,034,692	$553,110	$451,876	$302,942
Current Assets	$348,843,554	$337,476,192	$463,912,515	$194,550,775
Prepaid Assets	$3,426,090	$6,701,289	$5,783,453	$4,715,783
Receivables	$5,306,813	$3,433,435	$1,211,549	$445,975
Taxes Receivable	$5,306,813	$3,433,435	$1,211,549	$445,975
Cash Cash Equivalents And Short Term Investments	$340,110,651	$327,341,468	$456,193,616	$188,709,693
Cash And Cash Equivalents	$340,110,651	$327,341,468	$456,193,616	$188,709,693
Other Current Assets	-	-	$723,898	$679,325
Accounts Receivable	-	-	-	$0
Debt
Total Debt	$905,781	$1,004,513	$278,574	$509,354
Long Term Debt And Capital Lease Obligation	$672,324	$745,153	$50,798	$290,833
Current Debt And Capital Lease Obligation	$233,457	$259,360	$227,776	$218,521
Liabilities
Total Liabilities Net Minority Interest	$35,192,007	$27,535,010	$17,077,964	$21,541,457
Total Non Current Liabilities Net Minority Interest	$672,324	$745,153	$50,798	$290,833
Current Liabilities	$34,519,684	$26,789,857	$17,027,167	$21,250,624
Payables And Accrued Expenses	$20,955,483	$17,403,408	$9,928,953	$17,567,704
Payables	$7,060,862	$6,021,627	$3,894,178	$8,333,002
Total Tax Payable	$1,097,492	$701,081	$501,308	$1,361,024
Accounts Payable	$5,963,370	$5,320,546	$3,392,870	$6,971,978
Other Non Current Liabilities	-	-	-	-
Equity
Common Stock Equity	$316,318,027	$312,221,020	$447,817,643	$174,042,716
Total Equity Gross Minority Interest	$316,318,027	$312,221,020	$447,817,643	$174,042,716
Stockholders Equity	$316,318,027	$312,221,020	$447,817,643	$174,042,716
Gains Losses Not Affecting Retained Earnings	$58,880,562	$46,465,520	$32,509,576	$23,568,971
Other Equity Adjustments	$59,195,591	$46,304,925	$32,526,582	$23,518,493
Retained Earnings	$-675,835,260	$-469,047,359	$-310,073,033	$-191,451,604
Other
Ordinary Shares Number	$76,038,469	$63,408,923	$60,972,730	$39,431,506
Share Issued	$76,038,469	$63,408,923	$60,972,730	$39,431,506
Tangible Book Value	$316,318,027	$312,221,020	$447,817,643	$174,042,716
Invested Capital	$316,318,027	$312,221,020	$447,817,643	$174,042,716
Working Capital	$314,323,871	$310,686,334	$446,885,348	$173,300,150
Capital Lease Obligations	$905,781	$1,004,513	$278,574	$509,354
Total Capitalization	$316,318,027	$312,221,020	$447,817,643	$174,042,716
Foreign Currency Translation Adjustments	$-315,029	$160,595	$-17,006	$50,478
Additional Paid In Capital	$924,148,108	$727,193,788	$718,064,364	$337,193,567
Capital Stock	$9,124,617	$7,609,071	$7,316,736	$4,731,782
Common Stock	$9,124,617	$7,609,071	$7,316,736	$4,731,782
Long Term Capital Lease Obligation	$672,324	$745,153	$50,798	$290,833
Current Capital Lease Obligation	$233,457	$259,360	$227,776	$218,521
Pensionand Other Post Retirement Benefit Plans Current	$13,330,743	$9,127,090	$6,870,437	$3,464,398
Current Accrued Expenses	$13,894,621	$11,381,781	$6,034,775	$9,234,703
Net PPE	$1,631,788	$1,726,728	$531,216	$730,456
Accumulated Depreciation	$-477,246	$-256,688	$-146,191	$-76,406
Gross PPE	$2,109,033	$1,983,417	$677,407	$806,862
Other Properties	$2,109,033	$1,983,417	$677,407	$806,862

Fetched: 2026-08-25

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-160,025,951	$-140,704,617	$-108,604,336	$-78,459,575
Operating Activities
Operating Cash Flow	$-159,833,998	$-140,077,185	$-108,499,411	$-78,314,640
Cash Flow From Continuing Operating Activities	$-159,833,998	$-140,077,185	$-108,499,411	$-78,314,640
Operating Gains Losses	$13,692,173	$-8,545,987	$3,258,436	$-12,943,554
Investing Activities
Capital Expenditure	$-191,953	$-627,432	$-104,925	$-144,935
Investing Cash Flow	$-191,953	$-627,432	$-104,925	$-144,935
Cash Flow From Continuing Investing Activities	$-191,953	$-627,432	$-104,925	$-144,935
Financing Activities
Issuance Of Capital Stock	$200,253,790	$2,616,852	$399,849,958	$11,205,533
Financing Cash Flow	$187,275,213	$3,120,983	$379,422,816	$10,086,717
Cash Flow From Continuing Financing Activities	$187,275,213	$3,120,983	$379,422,816	$10,086,717
Net Other Financing Charges	$-12,723,199	$690,299	$-20,170,021	$-979,443
Net Common Stock Issuance	$200,253,790	$2,616,852	$399,849,958	$11,205,533
Common Stock Issuance	$200,253,790	$2,616,852	$399,849,958	$11,205,533
Other
Repayment Of Debt	$-255,379	$-186,167	$-257,121	$-139,374
End Cash Position	$340,110,651	$327,341,468	$456,193,616	$188,709,693
Beginning Cash Position	$327,341,468	$456,193,616	$188,709,693	$244,115,131
Effect Of Exchange Rate Changes	$-14,480,078	$8,731,486	$-3,334,556	$12,967,420
Changes In Cash	$27,249,261	$-137,583,634	$270,818,479	$-68,372,858
Net Issuance Payments Of Debt	$-255,379	$-186,167	$-257,121	$-139,374
Net Long Term Debt Issuance	$-255,379	$-186,167	$-257,121	$-139,374
Long Term Debt Payments	$-255,379	$-186,167	$-257,121	$-139,374
Net PPE Purchase And Sale	$-191,953	$-627,432	$-104,925	$-144,935
Purchase Of PPE	$-191,953	$-627,432	$-104,925	$-144,935
Taxes Refund Paid	$-2,528,842	$-3,226,734	$-1,292,456	$-213,181
Interest Received Cfo	$478,959	$6,316,574	$276,402	-
Change In Working Capital	$8,890,251	$6,867,955	$-6,836,118	$9,767,841
Change In Other Current Assets	$2,035,273	$-158,995	$-1,112,245	$-2,928,027
Change In Payables And Accrued Expense	$7,241,334	$7,066,964	$-5,676,006	$12,325,518
Change In Accrued Expense	$7,271,545	$5,139,288	$-811,279	$7,771,546
Change In Payable	$-30,211	$1,927,676	$-4,864,727	$4,553,972
Change In Receivables	$-386,356	$-40,014	$-47,867	$370,350
Other Non Cash Items	$-512,583	$-6,322,936	$-237,895	$45,772
Stock Based Compensation	$22,213,613	$18,899,876	$12,433,799	$13,233,676
Depreciation Amortization Depletion	$487,818	$314,321	$300,316	$178,336
Depreciation And Amortization	$487,818	$314,321	$300,316	$178,336
Depreciation	$487,818	$314,321	$300,316	$178,336
Net Foreign Currency Exchange Gain Loss	$13,692,173	$-8,545,987	$3,258,436	$-12,943,554
Net Income From Continuing Operations	$-202,555,387	$-154,380,254	$-116,401,895	$-88,215,335
Interest Paid Cfo	-	-	-	$-168,194

Fetched: 2026-08-25